HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 257 filers reported holding HERBALIFE LTD in Q4 2020. The put-call ratio across all filers is 2.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 8 | -99.4% | 0.00% | -100.0% |
| Q1 2020 | $39,000 | -39.1% | 1,349 | -0.6% | 0.00% | -25.0% |
| Q4 2019 | $64,000 | +8.5% | 1,357 | -13.0% | 0.00% | 0.0% |
| Q3 2019 | $59,000 | -24.4% | 1,559 | -13.9% | 0.00% | -20.0% |
| Q2 2019 | $78,000 | -6.0% | 1,811 | +16.2% | 0.01% | -28.6% |
| Q1 2019 | $83,000 | -9.8% | 1,559 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $92,000 | +8.2% | 1,559 | 0.0% | 0.01% | +33.3% |
| Q3 2018 | $85,000 | -100.0% | 1,559 | -89.4% | 0.01% | -91.2% |
| Q2 2018 | $789,416,000 | +231400.3% | 14,695 | +320.0% | 0.07% | +112.5% |
| Q1 2018 | $341,000 | +8425.0% | 3,499 | +5367.2% | 0.03% | – |
| Q4 2017 | $4,000 | -96.7% | 64 | -97.0% | 0.00% | -100.0% |
| Q1 2017 | $122,000 | -91.2% | 2,106 | -92.7% | 0.01% | -91.7% |
| Q4 2016 | $1,380,000 | -25.8% | 28,661 | -4.5% | 0.13% | -16.5% |
| Q3 2016 | $1,859,000 | +3280.0% | 30,012 | +3116.7% | 0.16% | +3060.0% |
| Q2 2016 | $55,000 | – | 933 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
| Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
| Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
| Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
| WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
| CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
| Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
| JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
| 683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
| Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |